Monthly Archives: July 2016

Smell Test May Predict Early Stages of Alzheimer’s Disease

Researchers from Columbia University Medical Center (CUMC), New York State Psychiatric Institute, and NewYork-Presbyterian reported that an odor identification test may prove useful in predicting cognitive decline and detecting early-stage Alzheimer’s disease.

Green polymer electrolyte based on N-phthaloylchitosan for dye-sensitized solar cells

A green polymer derived from bio-waste was applied to the dye-sensitized solar cells. Chitosan obtained from the insects’ and crustaceans’ chitin was modified to produce the phthaloylchitosan electrolyte for the dye-sensitized solar cells with efficiency of more than 7%.

NOVEL ANODE MATERIAL FOR LITHIUM-ION BATTERIES

Extensive research has been carried out to find a replacement for graphite as anode material. In this work, lithium tin vanadium oxide (LiSnVO4) has been synthesized via sol-gel method.

Fossil is Evidence of Earliest Human Cancer

Although the underlying cause of cancer is not fully known, modern medicine indicates that the disease is likely caused by today’s environment and lifestyles — factors, like diet, obesity and smoking.

Singapore scientists grow mini human brains

Scientists in Singapore have made a big leap on research on the ‘mini-brain’. These advanced mini versions of the human midbrain will help researchers develop treatments and conduct other studies into Parkinson’s Disease[1] (PD) and ageing-related brain diseases.

How comets are formed

Detailed analysis of data collected by Rosetta show that comets are the ancient leftovers of early Solar System formation, and not younger fragments resulting from subsequent collisions between other, larger bodies.

28 July, World Hepatitis Day

Among the deadliest diseases, hepatitis infection is widely spread around the world affecting 400 million people with hepatitis B and C, more than 10 times the number of people living with HIV. An estimated 1.45 million people died of the disease in 2013 – up from less than a million in 1990. Today, only 1 in 20 people with viral hepatitis know they have it. And just 1 in 100 with the disease is being treated.

Controlling anisotropy

The huge energy consumption of the world’s data centers creates an urgent need to develop electronic devices that can process information with reduced power requirements.

Macular degeneration insight identifies promising drugs to prevent vision loss

In a study published in the Proceedings of the National Academy of Sciences, a University of Wisconsin—Madison research team pinpoints how immune abnormalities beneath the retina result in macular degeneration, a common condition that often causes blindness.

Titanium + gold = new gold standard for artificial joints

Titanium is the leading material for artificial knee and hip joints because it’s strong, wear-resistant and nontoxic, but an unexpected discovery by Rice University physicists shows that the gold standard for artificial joints can be improved with the addition of some actual gold.

RSS
Follow by Email
Facebook
Google+
https://www.revoscience.com/en/2016/07">
Twitter